Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
Base and Covariate Population Pharmacokinetic Analyses of Dupilumab Using Phase 3 Data. [electronic resource] by
- Kovalenko, Pavel
- Davis, John D
- Li, Meng
- Rippley, Ronda
- Ardeleanu, Marius
- Shumel, Brad
- Graham, Neil M H
- Pirozzi, Gianluca
- Kamal, Mohamed A
- DiCioccio, A Thomas
Producer: 20210812
In:
Clinical pharmacology in drug development vol. 9
Availability: No items available.
|
|
6.
|
Systemic pharmacokinetic/pharmacodynamic analysis of intravitreal aflibercept injection in patients with retinal diseases. [electronic resource] by
- Kaiser, Peter K
- Kodjikian, Laurent
- Korobelnik, Jean-Francois
- Winkler, Julia
- Torri, Albert
- Zeitz, Oliver
- Vitti, Robert
- Ahlers, Cristiane
- Zimmermann, Torsten
- Dicioccio, A Thomas
- Höchel, Joachim
Publication details: BMJ open ophthalmology 2019
In:
BMJ open ophthalmology vol. 4
Availability: No items available.
|
|
7.
|
Relationship Between Low-Density Lipoprotein Cholesterol, Free Proprotein Convertase Subtilisin/Kexin Type 9, and Alirocumab Levels After Different Lipid-Lowering Strategies. [electronic resource] by
- Rey, Jacques
- Poitiers, Franck
- Paehler, Tobias
- Brunet, Aurélie
- DiCioccio, A Thomas
- Cannon, Christopher P
- Surks, Howard K
- Pinquier, Jean-Louis
- Hanotin, Corinne
- Sasiela, William J
Producer: 20180102
In:
Journal of the American Heart Association vol. 5
Availability: No items available.
|
|
8.
|
Relationship between alirocumab, PCSK9, and LDL-C levels in four phase 3 ODYSSEY trials using 75 and 150 mg doses. [electronic resource] by
- Robinson, Jennifer G
- Farnier, Michel
- Kastelein, John J P
- Roth, Eli M
- Taskinen, Marja-Riitta
- Colhoun, Helen M
- Brunet, Aurelie
- DiCioccio, A Thomas
- Lecorps, Guillaume
- Pordy, Robert
- Baccara-Dinet, Marie T
- Cannon, Christopher P
Producer: 20200720
In:
Journal of clinical lipidology vol. 13
Availability: No items available.
|
|
9.
|
Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. [electronic resource] by
- Van Zandt, Michael C
- Jones, Michael L
- Gunn, David E
- Geraci, Leo S
- Jones, J Howard
- Sawicki, Diane R
- Sredy, Janet
- Jacot, Jorge L
- Dicioccio, A Thomas
- Petrova, Tatiana
- Mitschler, Andre
- Podjarny, Alberto D
Producer: 20050603
In:
Journal of medicinal chemistry vol. 48
Availability: No items available.
|
|
10.
|
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Dupilumab in Healthy Adult Subjects. [electronic resource] by
- Li, Zhaoyang
- Radin, Allen
- Li, Meng
- Hamilton, Jennifer D
- Kajiwara, Miyuki
- Davis, John D
- Takahashi, Yoshinori
- Hasegawa, Setsuo
- Ming, Jeffrey E
- DiCioccio, A Thomas
- Li, Yongtao
- Kovalenko, Pavel
- Lu, Qiang
- Ortemann-Renon, Catherine
- Ardeleanu, Marius
- Swanson, Brian N
Producer: 20210812
In:
Clinical pharmacology in drug development vol. 9
Availability: No items available.
|
|
11.
|
A Phase I First-in-Human Study of Nesvacumab (REGN910), a Fully Human Anti-Angiopoietin-2 (Ang2) Monoclonal Antibody, in Patients with Advanced Solid Tumors. [electronic resource] by
- Papadopoulos, Kyriakos P
- Kelley, Robin Kate
- Tolcher, Anthony W
- Razak, Albiruni R Abdul
- Van Loon, Katherine
- Patnaik, Amita
- Bedard, Philippe L
- Alfaro, Ariceli A
- Beeram, Muralidhar
- Adriaens, Lieve
- Brownstein, Carrie M
- Lowy, Israel
- Kostic, Ana
- Trail, Pamela A
- Gao, Bo
- DiCioccio, A Thomas
- Siu, Lillian L
Producer: 20161213
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 22
Availability: No items available.
|